Further exploration in the Kaplan Meier database indicated that elevated SAA1 expression also correlated with shorter Recurrence-Free Survival (RFS) and Post-Progression Survival (PPS) in ovarian cancer patients (Fig. S2G-H). This evidence concerns the gene SAA1 and ovarian carcinoma.